High-dose chemotherapy with stem cell transplantation has been increasingly used in recent years. Nowadays, it is an important component in first-line as well as salvage therapy of malignant lymphomas within the German study groups.
The overall aim of the project was to improve data quality and availability, communication between study groups and transplant centres, patients, treating physicians, representatives of administration and health organisations, and thus further define the role of high-dose therapy in the treatment of patients with lymphoma.